Clinical Pharmacology and Pharmacogenomics

Sort by

Display

Collections

Format

Format

Author/ Creator

Show more

Year

Show more

Collection

Show more

Format

Author/ Creator

Show more

Year

Show more

Collection

Show more
Clinical Pharmacology and Pharmacogenomics 13 records found Search took 0.12 seconds. 
1.
Acute kidney injury (AKI) is a common syndrome in hospitalized patients and is associated with increased morbidity and mortality. The focus of AKI care requires a shift a [...]
29 October 2024 | Clinical Pharmacology and Pharmacogenomics[...] | Article |
2.
While therapeutic drug monitoring is a potentially attractive strategy that can be utilized by clinical pharmacologists to optimize drug dosing, the costs and risks must [...]
11 April 2024 | Clinical Pharmacology and Pharmacogenomics; Medicine | Article |
3.

Variation in gene expression has been observed in natural populations and associated with complex traits or phenotypes such as disease susceptibility and drug response [...]

21 October 2010 | Clinical Pharmacology and Pharmacogenomics; Human Genetics; Medicine; Public Health Sciences | Article |
4.

Annotating and interpreting the results of genome-wide association studies (GWAS) remains challenging. Assigning function to genetic variants as expression quantitativ [...]

03 April 2014 | Ben May Department for Cancer Research; Clinical Pharmacology and Pharmacogenomics; Genetics, Genomics, and Systems Biology; Human Genetics; Medicine | Article |
5.

To reduce treatment of indolent prostate cancer (PCa), biomarkers are needed to improve identification of patients with a low-risk of having aggressive disease. Over-t [...]

14 April 2015 | Clinical Pharmacology and Pharmacogenomics | Article |
6.

The discovery of expression quantitative trait loci (“eQTLs”) can help to unravel genetic contributions to complex traits. We identified genetic determinants of hu [...]

26 May 2011 | Clinical Pharmacology and Pharmacogenomics; Ecology and Evolution; Medicine | Article |
7.

Belinostat is a hydroxamate class HDAC inhibitor that has demonstrated activity in peripheral T-cell lymphoma and is undergoing clinical trials for non-hematologic mal [...]

30 January 2013 | Clinical Pharmacology and Pharmacogenomics; Medicine | Article |
8.
Quaternary derivatives of noroxymorphone are used to prevent or relieve nausea and emesis associated with the use of narcotic analgesics without interfering with the anal [...]
29 August 1989 | Clinical Pharmacology and Pharmacogenomics; Medicine | Patent |
9.
Quaternary derivatives of noroxymorphone are used to prevent or relieve nausea and emesis associated with the use of narcotic analgesics without interfering with the anal [...]
12 January 1988 | Clinical Pharmacology and Pharmacogenomics; Medicine | Patent |
10.
UDP-glucuronosyltransferases 1A isoforms belong to a superfamily of microsomal enzymes responsible for glucuronidation of numerous endogenous and exogenous compounds. The [...]
25 April 2007 | Ben May Department for Cancer Research; Clinical Pharmacology and Pharmacogenomics; Medicine | Article |
11.

Background: Hospitalizations are a vital opportunity for the initiation of life-saving opioid agonist therapy (OAT) for patients with opioid use disorder. A novel appr [...]

01 June 2023 | Clinical Pharmacology and Pharmacogenomics; Medicine | Article |
12.

Purpose: Frequencies of single nucleotide polymorphisms (SNPs) from pain related candidate genes are available for individuals with sickle cell disease (SCD). One of t [...]

11 November 2019 | Clinical Pharmacology and Pharmacogenomics | Article |
13.
Immune checkpoint inhibitors (ICI) are the standard of care for various malignancies and have been associated with a wide spectrum of complications that are phenotypicall [...]
08 February 2023 | Clinical Pharmacology and Pharmacogenomics; Medicine | Article |

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.